Back to Search
Start Over
Loperamide metabolite-induced cardiomyopathy and QTc prolongation.
- Source :
-
Clinical toxicology (Philadelphia, Pa.) [Clin Toxicol (Phila)] 2017 Aug; Vol. 55 (7), pp. 659-661. Date of Electronic Publication: 2017 Mar 28. - Publication Year :
- 2017
-
Abstract
- Loperamide is an over-the-counter, peripherally acting, μ-opioid receptor agonist used for the treatment of diarrhea. In recent times users have found that at higher doses, loperamide crosses the blood-brain barrier and reaches central μ-receptors in the brain, leading to central opiate effects including euphoria and respiratory depression. We report a case of a 37-year-old female who attempted suicide with over 200 loperamide tablets. During her overdose, her QTc was significantly prolonged at >600 ms. Our case aims to add to the growing body of literature describing life-threatening ventricular arrhythmias associated with loperamide toxicity and further suggests that a metabolite of loperamide, desmethylloperamide, may play a role in the pathogenesis.
- Subjects :
- Adult
Antidiarrheals pharmacokinetics
Biotransformation
Cardiomyopathies diagnosis
Cardiomyopathies physiopathology
Cardiomyopathies therapy
Electrocardiography
Female
Humans
Long QT Syndrome diagnosis
Long QT Syndrome physiopathology
Long QT Syndrome therapy
Loperamide analogs & derivatives
Loperamide pharmacokinetics
Predictive Value of Tests
Antidiarrheals poisoning
Cardiomyopathies chemically induced
Drug Overdose diagnosis
Drug Overdose physiopathology
Drug Overdose therapy
Long QT Syndrome chemically induced
Loperamide poisoning
Suicide, Attempted
Subjects
Details
- Language :
- English
- ISSN :
- 1556-9519
- Volume :
- 55
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Clinical toxicology (Philadelphia, Pa.)
- Publication Type :
- Academic Journal
- Accession number :
- 28349724
- Full Text :
- https://doi.org/10.1080/15563650.2017.1304555